Mylan - Top 10 Generic Drug Companies 2010

Mylan LabsCompany name: Mylan Labs
Location: Pittsburgh, PA
Annual sales (in millions): $3.620
Market share: 11.3%
CEO: Robert Coury

Like Teva, Mylan started out small. The company initially had only a handful of employees and a single office when it was founded in West Virginia in 1961 by Milan Puskar and Don Panoz.

Mylan saw revenues rise versus the same quarter last year--$1.37 billion versus $1.27 billion. But the company also narrowed its forecasted range of adjusted diluted EPS to $1.55 - $1.65 from $1.50 - $1.70. And net earnings totaled $51.5 million, or $0.16 per share, down from $58 million, or $0.19 per share during the same period 2009, when Mylan reported gains related to restructuring reserves and termination of joint ventures, as Reuters notes.

"The second quarter marks yet another quarter where we have met or exceeded our financial expectations," says Mylan Chairman and CEO Robert Coury. In our view, this quarter was exceptionally strong as it continues to demonstrate the underlying strength of our overall business. We were able to deliver adjusted diluted EPS of $0.37 despite many challenges, including the delay of certain product approvals, global pricing pressures and the impact of negative currency trends.

Mylan - Top 10 Generic Drug Companies 2010
Read more on

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.